Green Lifescience
그린생명과학 · 114450
Health Care Pharmaceuticals · KOSDAQ
Market cap US$35.2M (₩48.6B)
Overview
Green Lifescience makes the chemical building blocks, known as active pharmaceutical ingredients and intermediates, that drug companies use to manufacture finished medicines, as well as specialty chemicals for crop protection and electronic materials.
It supplies these products to global pharmaceutical companies and materials firms, sitting upstream in the supply chain as a contract manufacturer (a company that produces to a customer's specification). Listed on KOSDAQ, Korea's tech and small-cap board, the company is expanding its product portfolio beyond pharmaceutical ingredients into precision chemicals for circuit boards and QLED display materials.
Summary is AI-generated and may contain errors · figures from DART filings
Financials
Source: DART · FY ending Dec · latest FY2025Revenue
- FY2023US$16.2M
- FY2024US$18M
- FY2025US$29.2M
Operating profit
- FY2023−US$3.4M
- FY2024US$273.1K
- FY2025US$148K
Net income
- FY2023−US$11.9M
- FY2024US$1.1M
- FY2025US$79.8K
Key ratios (FY2025)
Why it matters
The company operates contract manufacturing using specialized capabilities including large-scale reactor equipment, phosgene reaction processes, and hydrogenation reaction technology, capabilities it explicitly highlights as a core strategic business.
Price charts coming soon
Interactive price history isn't here yet. Would you use it?